1 records matched your query
13170cam a22005174a 4500 001 F121F69A56D811DFB46C8AF9A7D7520A 003 SILO 005 20150520012456 008 080528s2009 caua be 001 0 eng 010 $a 2008022786 020 $a 1412950848 (cloth : alk. paper) 020 $a 9781412950848 (cloth : alk. paper) 035 $a (OCoLC)185031308 040 $a DNLM/DLC $c DLC $d SILO $d BAKER $d YDXCP $d NLM $d NOR $d C#P $d UKM $d IOK $d SILO 042 $a pcc 050 00 $a RC563.4 $b .E53 2009 060 00 $a 2009 C-313 060 10 $a WM 13 $b E5825 2009 082 00 $a 362.2903 $2 22 245 0 $a Encyclopedia of substance abuse prevention, treatment, & recovery / $c Gary L. Fisher, Nancy A. Roget, editors. 246 3 $a Encyclopedia of substance abuse prevention, treatment, and recovery 260 $a Los Angeles : $b SAGE, $c c2009. 300 $a 2 v. (xxxiii, 1092 p.) : $b ill. ; $c 29 cm. 500 $a "A SAGE reference publication." 504 $a Includes bibliographical references and index. 505 00 $g v. 2 -- $t Index. $t Reader's guide -- $t About the editors -- $t Contributors -- $t Introduction -- $t Entries -- $g v. 2 -- $t List of entries -- $t Reader's guide -- $t Entries -- $t Appendix : Entries related to specific drugs -- $t Index. 505 00 $t Aversive therapy -- $t Abstinence violation effect -- $t Acamprosate -- $t Acceptance and commitment therapy -- $t Access to recovery -- $t Addiction, models of -- $t Addiction severity index -- $t Addiction technology transfer centers -- $t Adolescents, substance abuse and treatment -- $t Adult children of alcoholics -- $t African Americans, issues in prevention and treatment -- $t Aftercare -- $t Al-Anon -- $t Alateen -- $t Alcohol -- $t Alcoholic personality -- $t Alcoholics Anonymous -- $t Alcohol-induced disorders -- $t Alcoholism -- $t Alcohol marketing -- $t Alcohol-related birth defects -- $t Alcohol testing -- $t Alcohol Use Disorders Identification Test -- $t Alternative activities -- $t American Society of Addiction Medicine -- $t Amotivational syndrome -- $t Amphetamines -- $t Amyl nitrite -- $t Anabolic steroids -- $t Anorexia nervosa -- $t Antabuse (disulfiram) -- $t Antianxiety agents -- $t Antidepressant drugs -- $t Antipsychotic drugs -- $t Antiseizure drugs -- $t Antisocial personality disorder -- $t Anxiety disorders -- $t Anxiolytic drugs -- $t Asian Americans/Pacific Islanders, issues in prevention and treatment -- $t Assessment -- $t Assessment instruments -- $t Athletes and drug use -- $t Attention deficit hyperactivity disorder -- $t Aversive conditioning -- $t Aversive therapy -- 505 00 $t COMBINE study -- $t Behavioral couples therapy -- $t Behavior risk factor surveillance system -- $t Behavioral therapy -- $t Benzodiazephines -- $t Biculturalism -- $t Big book, the -- $t Bill W. -- $t Binge drinking -- $t Biopsychosocial model of addiction -- $t Blood alcohol concentration -- $t Borderline personality disorder -- $t Brain chemistry and addiction -- $t Brief interventions -- $t Brief strategic family therapy -- $t Bulimia nervosa -- $t Buprenorphine -- $t Business improvement practices -- $t Caffeine -- $t CAGE screening instrument -- $t Cannabinols -- $t Cannabis youth treatment study -- $t CENAPS model -- $t Center for Substance Abuse Prevention -- $t Center for Substance Abuse Treatment -- $t Centers for the Application of Prevention Technologies -- $t Central nervous system depressants -- $t Central nervous system stimulants -- $t Certification and licensing -- $t Chemical dependency -- $t Children of alcoholics -- $t Chronicity -- $t Client engagement -- $t Client/treatment matching -- $t Clinical supervision of addiction counselors -- $t Club drugs -- $t Coalcoholic -- $t Cocaine and crack -- $t Cocaine Anonymous -- $t Codependency -- $t Coercion and treatment -- $t Cognitive behavioral therapy -- $t Cognitive-social learning model -- $t College on Problems of Drug Dependence -- $t College students, alcohol use and abuse -- $t College students, drug use and abuse -- $t COMBINE study -- 505 00 $t Drug laws, history of -- $t Community reinforcement and family training -- $t Community reinforcement approach -- $t Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513) -- $t Confidentiality -- $t Contingency management -- $t Continuum of care -- $t Co-occurring disorders -- $t Counseling approaches -- $t Court-mandated treatment -- $t Covert sensitization -- $t Crack -- $t Craving -- $t Crime and substance abuse -- $t Criminal justice populations -- $t Cross-addictions -- $t Cultural aspects -- $t Decriminalization -- $t Demand reduction -- $t Denial -- $t Depression -- $t Detoxification -- $t Diagnosis -- $t Diagnostic and Statistical Manual of Mental Disorders -- $t Disabilities, issues in prevention and treatment -- $t Discrimination, addicted and recovering individuals -- $t Disease concept -- $t Double trouble -- $t Driving under the influence -- $t Driving while intoxicated -- $t Drug abuse -- $t Drug abuse resistance education -- $t Drug abuse screening test -- $t Drug abuse treatment outcome studies -- $t Drug abuse warning network -- $t Drug addiction -- $t Drug courts -- $t Drug-crime cycle -- $t Drug-free Schools and Communities Act -- $t Drug laws, history of -- 505 00 $t Fidelity of prevention programs -- $t Drug testing -- $t Drug use, history of -- $t Dry drunk syndrome -- $t Dual relationships -- $t Eating disorders -- $t Economic costs of alcohol and drug abuse -- $t Ecstasy -- $t Elderly populations, treatment issues -- $t Electronic health records -- $t Empirically based prevention -- $t Empirically based treatment -- $t Employee Assistance Program -- $t Enabling -- $t Environmental approaches -- $t Ethical standards for addiction professionals -- $t Ethics -- $t Evidence-based prevention -- $t Evidence-based prevention and treatment, dissemination and adoption of -- $t Evidence-based treatment -- $t Expectancies -- $t Experimental substance use -- $t Family behavior therapy -- $t Family counseling -- $t Family therapy -- $t Fentanyl -- $t Fetal alcohol syndrome -- $t Fetal effects of alcohol and other drugs -- $t Fidelity of prevention programs -- 505 00 $t Inventory of drinking situations -- $t Gambling, pathological -- $t Gambling, problem -- $t Gateway drugs theory -- $t Gay, lesbian, bisexual, and transgender issues -- $t Gender issues -- $t Genetic aspects of addiction -- $t Grief, loss, and substance abuse -- $t Group therapy and counseling -- $t Hallucinogens -- $t Harm reduction, public health -- $t Harm reduction psychotherapy -- $t Hashish -- $t Health care system and substance abuse -- $t Health Insurance Portability and Accountability Act -- $t Hepatitis C -- $t Heroin -- $t High-risk behaviors -- $t High-risk situations -- $t Hispanics/Latinos, issues in prevention and treatment -- $t HIV/AIDS -- $t Homeless, substance abuse and treatment -- $t Issues in prevention ; racial and ethnic minorities -- $t Issues in treatment -- $t Ice -- $t Illicit and illegal drugs -- $t Impaired professionals -- $t Indian health services -- $t Information dissemination -- $t Informed consent -- $t Inhalants -- $t Injection drug use -- $t Inpatient treatment -- $t Institute of Medicine Classification System -- $t International Coalition for Addiction Studies Education -- $t Internet addiction -- $t Intervention -- $t Intravenous drug use -- $t Inventory of drinking situations -- 505 00 $t Multidimensional family therapy -- $t Johnson model intervention --- $t Join Together -- $t Legal Action Center -- $t Legalization of drugs -- $t Levo-alpha acetyl methadol -- $t Marijuana -- $t Maternal drug use -- $t Matrix model -- $t Media campaigns -- $t Medical consequences -- $t Medical use of marijuana -- $t Mentoring -- $t Methadone -- $t Methadone maintenance treatment -- $t Methamphetamine -- $t Methods of drug administration -- $t Michigan Alcohol Screening Test -- $t Minnesota model -- $t Moderation approaches to alcohol problems -- $t Moderation in use -- $t Moderation management -- $t Monitoring the future -- $t Moral model -- $t Morphine -- $t Motivational enhancement therapy -- $t Motivational interviewing -- $t Multiculturalism -- $t Multidimensional family therapy -- 505 00 $t Nicotine replacement therapy -- $t Naloxone -- $t Naltrexone -- $t Narcotics Anonymous -- $t National Clearinghouse for Alcohol and Drug Information -- $t National Council on Alcoholism and Drug Dependence -- $t National Council on Problem Gambling -- $t National Drug Control Strategy -- $t National Epidemiologic Survey on Alcohol and Related Conditions -- $t National Gambling Impact Study Commission -- $t National Institute of Mental Health -- $t National Institute on Alcohol Abuse and Alcoholism -- $t National Institute on Drug Abuse -- $t National Institute on Drug Abuse Clinical Trials Network -- $t National media campaign -- $t National outcome measures -- $t National Registry of Evidence-based Programs and Practices -- $t National Survey on Drug Use and Health -- $t National Treatment Improvement Evaluation Study -- $t Native Americans, issues in prevention and treatment -- $t Natural recovery -- $t Needle exchange programs -- $t Network for the improvement of addiction treatment -- $t Neurobiology of addiction -- $t Neurocognitive effects of alcohol and other drugs -- $t Neurotransmitters -- $t Nicotine -- $t Nicotine replacement therapy -- 505 00 $t Routes of administration of drugs -- $t Opiates -- $t Opioids -- $t Other addictions -- $t Outpatient treatment -- $t Over-the-counter drugs -- $t OxyContin -- $t Pain management -- $t Patient placement criteria -- $t Peer recovery support services -- $t Pharmacological approaches to treatment -- $t Physiological aspects of drug use -- $t Post-traumatic stress disorder -- $t Prescription drugs -- $t Prevention education -- $t Prevention evaluation -- $t Prevention populations -- $t Prevention programs -- $t Prevention strategies -- $t Problem identification and referral -- $t Problem oriented screening instrument for teenagers -- $t Project MATCH -- $t Psychological models of addiction -- $t Psychosocial history -- $t Public policy, alcohol -- $t Public policy, drugs -- $t Public policy, prevention -- $t Public policy, treatment -- $t Pulse check -- $t Qualified services organization agreements -- $t Racial and ethnic minorities, issues in alcohol and other drug use -- $t Racial and ethnic minorities, issues in prevention -- $t Rapid opioid detoxification -- $t Rational recovery -- $t Recovery -- $t Recovery community organizations -- $t Recovery community services program -- $t Recovery schools -- $t Recovery support services -- $t Refusal skills -- $t Relapse -- $t Relapse prevention -- $t Research issues in prevention -- $t Research issues in treatment -- $t Residential treatment -- $t Resistance in treatment -- $t Reverse tolerance -- $t Risk and protective factor theory -- $t Risk factors for addiction -- $t Routes of administration of drugs -- 505 00 $t Synar amendment -- $t School drug policies -- $t Scope of practice -- $t Screening -- $t Screening instruments -- $t Secular organizations for sobriety/Save Our Selves -- $t Sedative-hypnotics -- $t Self-change -- $t Self-help groups -- $t Self-report inventories -- $t Sex addiction -- $t Sexually transmitted diseases -- $t Shopping addiction -- $t Single state authorities -- $t Sobriety -- $t Social drinking -- $t Social learning model of addictive behaviors -- $t Social norms marketing -- $t Social skills training -- $t Sociocultural models of addiction -- $t Solution-focused therapy -- $t Special populations -- $t Spiritual issues -- $t Spontaneous remission -- $t Stages of change model -- $t State provider associations -- $t STD -- $t Steroids -- $t Stigma -- $t Student assistance program -- $t Substance abuse -- $t Substance abuse and mental health services administration -- $t Substance abuse subtle screening inventory-3 -- $t Substance dependence -- $t Substance-induced disorders -- $t Substance-induced withdrawal delirium -- $t Substance use disorders -- $t Substitute addictions -- $t Suicide -- $t Supply reduction -- $t Support groups -- $t Synanon -- $t Synar amendment -- 505 00 $t Workplace prevention. $t Timeline followback -- $t Tobacco -- $t Tobacco cessation programs and treatments -- $t Tobacco marketing and countermarketing -- $t Tobacco master settlement agreement -- $t Tolerance -- $t Treatment, history of -- $t Treatment, nontraditional approaches -- $t Treatment access and retention -- $t Treatment approaches and strategies -- $t Treatment effectiveness -- $t Treatment facilities -- $t Treatment in jails and prisons -- $t Treatment of alcohol and drug use disorders -- $t Treatment plans and treatment planning -- $t Treatment programs for alcohol or drug abuse -- $t Treatment settings -- $t Tuberculosis -- $t Twelve-step facilitation -- $t Twelve-step recovery programs -- $t Twelve steps -- $t Underage drinking -- $t Urine toxicology testing -- $t Veterans, substance abuse and treatment -- $t Violence, intimate partner and substance abuse treatment -- $t Violence prevention -- $t War on drugs -- $t Welfare reform and substance abuse -- $t Willpower -- $t Withdrawal -- $t Women for sobriety -- $t Womens' issues in prevention and treatment -- $t Workplace drug policies -- $t Workplace drug use -- $t Workplace prevention. 650 0 $a Substance abuse $v Encyclopedias. 650 12 $a Substance-Related Disorders $v Encyclopedias $x English. 700 1 $a Fisher, Gary L. 700 1 $a Roget, Nancy A. 856 42 $z Additional Information at Google Books $u http://books.google.com/books?isbn=9781412950848 941 $a 2 952 $l OVUX522 $d 20231018020956.0 952 $l SOAX911 $d 20100503150322.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=F121F69A56D811DFB46C8AF9A7D7520A 994 $a 02 $b IOKInitiate Another SILO Locator Search